Introduction:
Did you know that the botulinum toxin (BT) holds its uses in the field of oral and maxillofacial surgery as well? Primarily as the botulinum toxin is used in cosmetic surgeries, many therapeutic benefits of BT have been unexplored by researchers. With the advent of cosmetic therapies and with the latest technological therapeutic interventions now leading up to the global pace, BT is indeed considered a therapeutic alternative in the field of maxillofacial surgery. Let us explore more about the action or the mechanism of BT and its possible uses in this field as a potent therapeutic agent.
What Is Botulinum Toxin?
Botulinum toxin (BT) is one of the most poisonous and powerful toxins known to mankind that exerts an extremely potent biological effect on human tissues. In fact, in comparison to cyanide toxins, BT can be proven more dangerous in terms of its poisonous nature, according to medical researchers. According to current medical research, BT is almost 40 million times as powerful or more potent than cyanides. Although these are known more commonly in cosmetic fields for reducing facial wrinkles or lines and for purposes of cosmetic surgery or even in relieving chronic headaches, and pains from migraines (a type of headache causing throbbing pain or pulsating in one side of the head), there is much more potential to BT than you would be aware of.
These are complex proteins that are secreted by gram-positive anaerobic bacteria from the Clostridium genus. It is known to be a therapeutic option in medical fields, especially in the area of maxillofacial surgery. This is due to the antigenic properties that it possesses, which can help stabilize painful conditions or muscle-related pathologies commonly. We will be exploring the scope of BT by deciphering its primary mechanism of action and its therapeutic uses in modern-day surgery.
What Are the Types of Botulinum Toxin and How Does It Work?
There are nearly seven types of botulinum toxin, also known as serotypes, with researchers investigating the biological impact of different serotypes on human tissues. These investigations focus on their antigenic-based properties, which range primarily from type A to type G. Commercially, only BT types A and B are available as therapeutic interventions based on the management strategy. These serotypes A and B are now commercially utilized for therapeutic interventions in medicine ranging from treatment of esophageal motor disorders in gastroenterology, urology-pertaining diseases, overactive urinary bladder, hemifacial spasms of muscles (involuntary muscle contraction on one side of the face), in the ophthalmology field, treatment of hyperhidrosis (excess sweating beyond physiological need), myoclonus (sudden involuntary muscle jerks), dysphagia (difficulty swallowing), and more - to name a few of its uses or applications medically in several interventional strategies.
Serotypes A and B are approximately estimated to be around 300 to 900 kDa (kilodalton) in size, possessing scope for the neuroactive potential of the BoNT (botulinum neurotoxin). The mechanism of action is by bringing with it the nontoxic protein molecules in the affected regions of the body that can help stabilize this complex protein molecule.
Further, in the medical field, in the cosmetic surgery field especially, BT is a potent muscle relaxant that tends to inhibit gland-based secretions in the human body. It can block the release of acetylcholine neurotransmitters, thereby inhibiting the activation of the muscle fibers. It only produces a transient block within the muscle activation, thereby making it extremely safe and clinically relevant in several biological applications in medicine and maxillofacial surgery.
What Are the Therapeutic Uses of Botulinum Toxin in Maxillofacial Surgery?
The many orofacial uses of botulinum toxin (BT) are now coming to light from the perspective of the recent advent of maxillofacial surgery technologies.
-
In the clinical management of myofascial pains, BT is commonly used.
-
BT is commonly utilized in treating hypertonic (increased muscle tone) superior lip or labial muscles.
-
It is used in the management of pain for patients suffering from chronic and untreated parafunctional habits like bruxism (involuntary habitual grinding of teeth causing jaw pain). In these individuals, often as a result of lack of timely management, chronic jaw pain or dental pain can be a symptom that can compromise the patient's oral quality of life.
-
BT is used in the management of hypertrophy of the masseter muscle. Masseter hypertrophy is one of the functional disturbances commonly encountered clinically by oral and maxillofacial surgeons or dentists due to benign enlargement within the volume of the facial masseter muscle that can compromise the facial form and function as well.
-
In patients suffering from chronic orofacial syndromes or disorders in which their mouth opening becomes extremely limited, either as a result of post-operative side effects or due to functional debilitation or surgical injury, BT can rectify the mouth opening limitation (MOL) in these cases.
-
The use of BT would be reserved only for specialized oral surgeries by the maxillofacial surgeon commonly. For instance, as a first-line treatment or gold standard management strategy in the Frey's syndrome (sweating and flushing of the skin in the cheek region), in treating complicated salivary gland disorders that are aberrant, or in even managing sialo-oral fistulas (abnormal connections between salivary glands and oral cavity), BT injections can be used as the primary measure by the maxillofacial or the plastic or cosmetic surgeon.
-
In muscular pathologies affecting the face or the jaw, especially in treating myalgia or myalgic pain affecting the masticatory muscles lower jaw (mandible), or the mandibular elevator muscles, BT holds promising current and future therapeutic potential for effectively relieving pain.
Botulinum toxin injections are considered safe by both maxillofacial surgeons and physicians in the current scope and modern-day medical practice, given their noninvasive potential and first-line treatment potential in muscular pathologies for relieving pain effectively.
Conclusion
To conclude, BT in oral and maxillofacial surgery is primarily a first-line therapeutic intervention meant for certain conditions like masseter muscle hypertrophy, bruxism, myalgia pain, and muscular pathologies affecting the face and jaw. There is promising future potential for this minimally invasive pain relief system, especially in restoring patients' oral or jaw esthetics and functions because of its ability as a muscular relaxant and transient, but effective inhibitory properties in affected orofacial muscles.
